Harel Insurance Investments & Financial Services Ltd. purchased a new stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 52,624 shares of the semiconductor company’s stock, valued at approximately $25,964,000.
A number of other hedge funds and other institutional investors have also made changes to their positions in SNPS. Bank Hapoalim BM increased its holdings in Synopsys by 262.1% during the 3rd quarter. Bank Hapoalim BM now owns 1,539 shares of the semiconductor company’s stock worth $759,000 after purchasing an additional 1,114 shares in the last quarter. Maryland State Retirement & Pension System grew its holdings in shares of Synopsys by 22.6% during the third quarter. Maryland State Retirement & Pension System now owns 9,194 shares of the semiconductor company’s stock worth $4,536,000 after buying an additional 1,693 shares in the last quarter. Sequoia Financial Advisors LLC raised its position in Synopsys by 19.2% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 10,628 shares of the semiconductor company’s stock valued at $5,244,000 after buying an additional 1,713 shares during the last quarter. Evergreen Capital Management LLC lifted its stake in Synopsys by 68.3% in the 3rd quarter. Evergreen Capital Management LLC now owns 2,651 shares of the semiconductor company’s stock valued at $1,308,000 after acquiring an additional 1,076 shares in the last quarter. Finally, NBT Bank N A NY boosted its position in Synopsys by 13.4% during the 3rd quarter. NBT Bank N A NY now owns 279 shares of the semiconductor company’s stock worth $138,000 after acquiring an additional 33 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Synopsys Stock Performance
SNPS opened at $516.31 on Friday. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $651.73. The business has a 50 day moving average of $455.35 and a 200-day moving average of $504.95. The stock has a market cap of $98.78 billion, a price-to-earnings ratio of 64.62, a PEG ratio of 4.30 and a beta of 1.12.
Wall Street Analysts Forecast Growth
SNPS has been the topic of a number of research reports. Piper Sandler lowered shares of Synopsys from an “overweight” rating to a “neutral” rating and cut their price objective for the stock from $602.00 to $520.00 in a research report on Tuesday. Citigroup began coverage on shares of Synopsys in a research note on Monday, November 24th. They set a “buy” rating and a $580.00 price objective for the company. BNP Paribas started coverage on Synopsys in a report on Thursday, October 2nd. They issued an “underperform” rating and a $425.00 price objective for the company. Morgan Stanley upped their target price on Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a report on Friday, December 12th. Finally, Bank of America upgraded Synopsys from an “underperform” rating to a “neutral” rating and decreased their price target for the company from $525.00 to $500.00 in a research note on Monday, December 8th. Nine analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $553.57.
Read Our Latest Stock Analysis on SNPS
Insider Activity
In related news, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the sale, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Janet Lee sold 250 shares of the company’s stock in a transaction on Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the transaction, the insider directly owned 11,959 shares in the company, valued at approximately $6,338,270. This represents a 2.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 4,157 shares of company stock worth $1,945,036. Insiders own 0.62% of the company’s stock.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- Wall Street Alert: Buy AES
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
